Lilly rides Mounjaro, Zepbound to better
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit.
The drugmaker also hiked its sales and earnings forecast for 2024 beyond Wall Street’s expectations even as it hustles to boost manufacturing and catch up to surging demand for the drugs.
Lilly said it was still dealing with supply issues that also hampered the company in the fourth quarter. Company officials expect that to persist through this year, but they emphasized Tuesday that help was on the way.
They expect significant manufacturing increases to occur, starting in the back half of the year.
CEO David Ricks told analysts Tuesday that Lilly was undergoing “the most ambitious expansion plan in our company’s history.”
Indianapolis-based Eli Lilly and Co. recorded $517 million in sales from Zepbound, which received approval from U.S. regulators last November. Total Mounjaro sales more than tripled to $1.81 billion from $568 million in last year’s quarter.
Related articles
Liverpool confirms Arne Slot as Jurgen Klopp's replacement
Arne Slot will take on one of the most daunting challenges in soccer by replacing Jurgen Klopp as Li2024-05-21Japanese game maker Sega Sammy sells resort to US fund
TOKYO (AP) — Sega Sammy is selling its resort complex Seagaia to Fortress Investment Group of the U.2024-05-21- LOS ANGELES (AP) — The average rate on a 30-year mortgage fell for the first time in four weeks, a s2024-05-21
Man paralyzed after being hit with a Taser while running from police in Colorado sues officer
DENVER (AP) — A man who said he was paralyzed after being hit with a Taser while running from police2024-05-21Kristin Cavallari, 37, ignores critics of her age
Kristin Cavallari is enjoying a romantic rendezvous with her much younger cowboy lover Mark Estes in2024-05-21Biden and Netanyahu's relationship faces strain of deepening war
WASHINGTON (AP) — President Joe Biden and Israeli Prime Minister Benjamin Netanyahu have long manage2024-05-21
atest comment